BACKGROUND: Recent meta-analyses suggest that the effectiveness of cardiac devices may differ between genders. Compared to men, women may not benefit as much from implantable cardioverter-defibrillators (ICDs), yet benefit more from cardiac resynchronization therapy (CRT). Myocardial scar burden is associated with increased incidence of appropriate ICD shocks but decreased response to CRT and may explain gender differences in device benefit. OBJECTIVE: To test the hypothesis that the extent of myocardial scar is less in women than men. METHODS: In 235 patients referred for primary prevention ICDs who underwent cardiac magnetic resonance imaging, we compared scar size by gender. Analyses were performed for all patients (ICD cohort) and those receiving biventricular pacemakers (CRT subgroup). RESULTS: In the ICD cohort, women (vs men) had a higher prevalence of nonischemic cardiomyopathy (NICM; 64% vs 39%; P<.001), which accounted for a smaller overall scar burden (0.5% vs 13%, P<.01). Likewise, in the CRT subgroup, the higher prevalence of NICM in women (83% vs 46%; P = .01) also contributed to a smaller scar size (0% vs 13%; P<.01). Women also had significantly less scarring of the inferolateral left ventricular wall. CONCLUSIONS: In a cohort of patients undergoing clinically indicated ICD and CRT, women had less myocardial scar than did men. This difference was primarily driven by a higher prevalence of NICM in women. These findings may have important implications for the future study of gender disparities in ICD and CRT outcomes.
BACKGROUND: Recent meta-analyses suggest that the effectiveness of cardiac devices may differ between genders. Compared to men, women may not benefit as much from implantable cardioverter-defibrillators (ICDs), yet benefit more from cardiac resynchronization therapy (CRT). Myocardial scar burden is associated with increased incidence of appropriate ICD shocks but decreased response to CRT and may explain gender differences in device benefit. OBJECTIVE: To test the hypothesis that the extent of myocardial scar is less in women than men. METHODS: In 235 patients referred for primary prevention ICDs who underwent cardiac magnetic resonance imaging, we compared scar size by gender. Analyses were performed for all patients (ICD cohort) and those receiving biventricular pacemakers (CRT subgroup). RESULTS: In the ICD cohort, women (vs men) had a higher prevalence of nonischemic cardiomyopathy (NICM; 64% vs 39%; P<.001), which accounted for a smaller overall scar burden (0.5% vs 13%, P<.01). Likewise, in the CRT subgroup, the higher prevalence of NICM in women (83% vs 46%; P = .01) also contributed to a smaller scar size (0% vs 13%; P<.01). Women also had significantly less scarring of the inferolateral left ventricular wall. CONCLUSIONS: In a cohort of patients undergoing clinically indicated ICD and CRT, women had less myocardial scar than did men. This difference was primarily driven by a higher prevalence of NICM in women. These findings may have important implications for the future study of gender disparities in ICD and CRT outcomes.
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Andrew E Epstein; John P Dimarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney Journal: Heart Rhythm Date: 2008-05-19 Impact factor: 6.343
Authors: Stijntje D Roes; C Jan Willem Borleffs; Rob J van der Geest; Jos J M Westenberg; Nina Ajmone Marsan; Theodorus A M Kaandorp; Johan H C Reiber; Katja Zeppenfeld; Hildo J Lamb; Albert de Roos; Martin J Schalij; Jeroen J Bax Journal: Circ Cardiovasc Imaging Date: 2009-03-23 Impact factor: 7.792
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: Eline A Q Mooyaart; Nina Ajmone Marsan; Rutger J van Bommel; Joep Thijssen; C Jan Willem Borleffs; Victoria Delgado; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: Am J Cardiol Date: 2011-04-27 Impact factor: 2.778
Authors: Pamela N Peterson; Stacie L Daugherty; Yongfei Wang; Humberto J Vidaillet; Paul A Heidenreich; Jeptha P Curtis; Frederick A Masoudi Journal: Circulation Date: 2009-02-16 Impact factor: 29.690
Authors: Alida E Borger van der Burg; Jeroen J Bax; Eric Boersma; Ernest K J Pauwels; Ernst E van der Wall; Martin J Schalij Journal: Circulation Date: 2003-10-06 Impact factor: 29.690
Authors: Robbert Zusterzeel; Kimberly A Selzman; William E Sanders; Kathryn M O'Callaghan; Daniel A Caños; Kevin Vernooy; Frits W Prinzen; Anton P M Gorgels; David G Strauss Journal: J Cardiovasc Transl Res Date: 2015-12-10 Impact factor: 4.132
Authors: Daniel J Friedman; Kasper Emerek; Peter L Sørensen; Emily P Zeitler; Sarah A Goldstein; Sana M Al-Khatib; Peter Søgaard; Claus Graff; Brett D Atwater Journal: Heart Rhythm O2 Date: 2020-08-04